SecureBio says Anthropic's evaluator update misdescribed its publication rights and Anthropic revised it
SecureBio · Company post
Read the source (opens in a new tab)- What happened
- SecureBio published a response on October 16, 2026 to Anthropic's update on independent evaluators from the day before, which had placed SecureBio "in the first tier" of a tiered access system.
- Key points
- "This description did not reflect the agreement we have with Anthropic, and Anthropic has since revised it," SecureBio writes; it "has not agreed to any formal tier designation with Anthropic."
- Its one ongoing assessment is an independent review of the chemical and biological weapons chapter of Anthropic's August 2026 Risk Report, and under its terms SecureBio "may publish our results and methodology without Anthropic's approval."
- Anthropic may designate sensitive material for redaction, and SecureBio's public report "will state whether any redactions were made and whether they affected our findings."
- SecureBio says it may accept limited publication rights for pilot work meant to strengthen a developer's safeguards against biological misuse, and will keep pushing "for independence and publication rights for third-party evaluators."
- Evidence
- The evaluator's own statement of its contract terms, published on its Substack. It says Anthropic revised its description but does not quote the original or revised wording.